Recap: Nabriva Therapeutics Q2 Earnings


Nabriva Therapeutics NBRV reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Nabriva Therapeutics beat estimated earnings by 10.0%, reporting an EPS of $-0.18 versus an estimate of $-0.2.

Revenue was up $948 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 10.32% drop in the share price the next day.

Here's a look at Nabriva Therapeutics's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.19 -0.19 -0.24 -0.35
EPS Actual -0.20 -0.24 -0.21 -0.29
Revenue Estimate 9.57M 10.10M 9.50M 5.99M
Revenue Actual 8.02M 9.26M 8.86M 8.24M

To track all earnings releases for Nabriva Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: EarningsBZI-Recaps